Project Grant R01AG097831
- The National Institute on Aging awarded Drexel University $420,554 under Aging Research (CFDA 93.866) on September 1, 2026, to establish an integrated system for studying senescence and aging in the central nervous system. The award funds two research aims: characterization of the molecular and functional consequences of senescence in astrocyte and neuronal cultures, and evaluation of senescence impact in a multicellular context using hiPSC-derived vascularized cortical organoids. Single-cell...
- The National Institute on Aging awarded the University of Pennsylvania $825,128 on September 1, 2026, under the Aging Research program (CFDA 93.866) to identify drivers of variation in home health outcomes and clarify how differences in care processes contribute to disparities in patient outcomes across demographic groups. The project will develop group-specific process and outcome measures to assess variations in care by patient grouping, addressing gaps in current Medicare quality metrics that...
- The National Institute on Aging awarded the University of Pennsylvania $811,172 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a five-year prospective observational study testing whether economic scarcity affects medication adherence and uptake of preventive services among older adults with chronic disease. The research enrolls 400 adults aged 50 years or older who receive Supplemental Nutrition Assistance Program (SNAP) benefits and are prescribed once-daily...
- The National Institute on Aging awarded New York University $466,125 under the Aging Research program (CFDA 93.866) on January 15, 2026, to develop innovative magnetic resonance imaging analysis tools for identifying microstructural biomarkers of skeletal muscle health across the lifespan. The project, titled "(Micro)structural Biomarkers of Skeletal Muscle Health Across the Lifespan," addresses sarcopenia—a leading cause of disability and mortality in aging populations—by creating...
- The National Institute on Aging awarded the University of California Irvine $5,101,916 on July 1, 2026, under the Aging Research program (CFDA 93.866) to examine daily dynamics of social connection and their influence on physical and cognitive functioning across the adult lifespan. The research uses longitudinal daily diary datasets from the Midlife in the United States Study (MIDUS), including four waves of diary data across approximately 20 years (beginning in 2002, 2014, and 2023) and two...
- The National Institute on Aging awarded the University of Memphis $146,000 on September 4, 2026, under the Aging Research program (CFDA 93.866) to investigate longitudinal patterns of multiple behavioral risk factors and their joint effects on cognitive aging. The recipient will analyze 24 years of data from the Health and Retirement Study, a nationally representative longitudinal survey of U.S. adults age 51 and older, linked with neighborhood contextual data, to examine how physical...
- The National Institute on Aging awarded the National Bureau of Economic Research Inc. $427,646 on September 1, 2026, under the Aging Research program (CFDA 93.866) to trace mid-life mortality of birth cohorts born approximately 1940–1960 in the United States by place, time, and family factors. The research combines large-scale administrative datasets—the Numident, Bureau of the Census Numident Mortality Detail file, and Mortality Linkage Project data, containing more than 3.5 million death...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded $533,500 to the Buck Institute for Research on Aging on July 15, 2026, under the Aging Research program (CFDA 93.866). The award funds examination of the role of autonomic innervation in muscle stem cell aging. The research investigates the functional link between autonomic nervous system neurons and muscle stem cells using Drosophila melanogaster as a model organism. The project will refine...
- The National Institute on Aging awarded the University of California, Los Angeles $623,176 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research on modifiable risk factors for Alzheimer's disease and related dementias among individuals aged 90 and older. The research triangulates evidence across four data sources—the LifeAfter90 Study (1,397 participants, all aged 90), the 90+ Study (1,630 participants, all aged 90), the Health and Retirement Study (3,359...
- The National Institute on Aging awarded Northwestern University $1,341,808 on February 15, 2026, under the Aging Research program (CFDA 93.866) to conduct longitudinal research on aging-in-place and long-term care decision-making among older adults with Alzheimer's dementia. The research extends a current cohort study (R01AG058777) of 293 older adults with a 94.5 percent retention rate. Northwestern will follow subjects every six months through 42 months with surveys examining how aging-in-place...
The National Institute on Aging awarded Drexel University $1,306,728 under the Aging Research program (CFDA 93.866) on August 1, 2026, to conduct a longitudinal, multi-site study examining how individual lifestyle, social circumstances, and neighborhood-level factors influence physical functioning trajectories in older adults across population subgroups and U.S. regions. The research leverages over 30 years of longitudinal data from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort and proposes four large-scale data collection processes—geographic information systems (GIS) mapping, virtual systematic neighborhood audits, participant surveys, and community-informant surveys—to expand contextual neighborhood data. The study pairs these neighborhood datasets with performance-based objective physical function assessments (Short Physical Performance Battery) and self-reported physical function and disability measures to identify modifiable risk factors amenable to intervention, with particular focus on high-risk populations experiencing persistent disability declines. Work is performed in Pennsylvania. The period of performance runs from August 1, 2026 through April 30, 2031. This is a Project Grant, the standard assistance type under the Aging Research program for biomedical and behavioral research directed toward understanding aging processes and age-related diseases and needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.3m | 7/24/26 |